Citadel Advisors’s VolitionRx VNRX Stock Holding History
Bought
Maintained
Sold
Other funds holding VNRX
Citadel Advisors's VNRX Position: Q3 2026 in Review
Citadel Advisors opened a new position in VolitionRx (VNRX) in Q3 2026: 47,656 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #13759 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in VNRX as recently as Q4 2025.
Citadel Advisors first reported a position in VNRX in Q2 2020 and has held it in 15 quarters since. The position peaked at $224K in Q3 2025. 28 funds tracked by Wall St. Rank hold VNRX as of Q3 2026.
- Citadel Advisors held 47,656 shares of VolitionRx worth $12.3K as of Q3 2026.
- VolitionRx was a new Citadel Advisors position in Q3 2026.
- VolitionRx made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13759 holding.
- Citadel Advisors first reported a position in VolitionRx in Q2 2020 and has held it in 15 quarters since.
- Citadel Advisors's VolitionRx position peaked at $224K in Q3 2025.
- 28 funds tracked by Wall St. Rank held VolitionRx as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.